Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Very strong margins and returns
About
Established on July 1, 2000, NeoPharm Co., Ltd. is a Daejeon, South Korea-based company that develops, produces, and markets a diverse range of cosmetic, medical, and health products. Its offerings notably include advanced skincare formulations, both emulsified and functional, designed to address issues such as sensitive and dry skin, as well as to provide treatment for atopic dermatitis, psoriasis, and the adverse effects associated with steroid use.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r
Target Price
The average target price of 092730.KQ is 30000 and suggests 36.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t